Luther King Capital Management (LKCM)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-21,915
Closed -$266K 617
2022
Q1
$266K Sell
21,915
-82,940
-79% -$1.75M ﹤0.01% 562
2021
Q4
$3.58M Sell
104,855
-21,450
-17% -$840K 0.02% 250
2021
Q3
$6.09M Sell
126,305
-4,010
-3% -$186K 0.03% 182
2021
Q2
$5.89M Sell
130,315
-14,290
-10% -$633K 0.03% 195
2021
Q1
$6.97M Sell
144,605
-16,610
-10% -$865K 0.04% 166
2020
Q4
$8.68M Sell
161,215
-2,175
-1% -$98.3K 0.05% 152
2020
Q3
$6.03M Sell
163,390
-6,180
-4% -$230K 0.04% 155
2020
Q2
$5.25M Buy
169,570
+9,880
+6% +$274K 0.04% 162
2020
Q1
$4.41M Sell
159,690
-10,380
-6% -$311K 0.04% 163
2019
Q4
$4.97M Buy
170,070
+10,880
+7% +$259K 0.03% 181
2019
Q3
$3.04M Sell
159,190
-377
-0.2% -$8.84K 0.02% 221
2019
Q2
$3.5M Buy
159,567
+16,117
+11% +$354K 0.03% 206
2019
Q1
$2.94M Buy
+143,450
New +$2.49M 0.02% 227

Other funds holding NEO

Luther King Capital Management (LKCM)'s NEO Position: Q2 2022 in Review

Luther King Capital Management (LKCM) sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 21,915 shares — an estimated $266K sold.

Luther King Capital Management (LKCM) first reported a position in NEO in Q1 2019 and held it in 13 quarters. The position peaked at $8.68M in Q4 2020. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Luther King Capital Management (LKCM) reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 21,915 NeoGenomics shares in Q2 2022, an estimated $266K.
  • Luther King Capital Management (LKCM) first reported a position in NeoGenomics in Q1 2019 and held it in 13 quarters.
  • Luther King Capital Management (LKCM)'s NeoGenomics position peaked at $8.68M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2022, filed 11 Aug 2022.